-
Related books
Apoptosis, Cell Signaling, and Human Diseases: Molecular Mechanisms, Volume 2
by Rakesh Srivastava (Hardcover - Mar 19, 2007)
Excerpt:
... "stress and apoptosis in myeloma cells by the aziridine-containing agent imexon. Biochem Pharmacol 2000;60:749-758. 197. McLaughlin KA, Osborne BA, Goldsby RA." ...
More about this bookNatural Compounds in Cancer Therapy: Promising Nontoxic Antitumor Agents From Plants & Other Natural Sources
by John Boik and Israel Barken (Paperback - Mar 2001)
Excerpt:
... "HI-240 1 24 35 ICI D 1694 15 6.7 36 Imexon 21 4.9 37 Melatonin 54 1.4 3 8 midazolam 3.9" ...
More about this bookMonoclonal Antibodies in Biotechnology: Theoretical and Practical Aspects (Cambridge Studies in Biotechnology)
by Kenneth C. McCullough and Raymond E. Spier (Paperback - Mar 19, 2009)
Excerpt:
... "polymers of polyoxyethylene and polyoxypropylene) aziridine derivatives: imexon azimexon tilorone DDA CP-20, 961 (Avridine) CP-46, 665 CCA (Lobenzarit)" ...
More about this bookSpanish Chemical and Pharmaceutical Glossary: English-Spanish, Spanish-English
by Hilda Zayas (Paperback - Dec 25, 2005)
Excerpt:
... "iloprost iloprost iludins iludinos imandrite imandrita imbibition imbibicin imcarbofos incarbofs imexon imcxn imiclopazine imiclopacina," ...
More about this bookBasic & Clinical Pharmacology
by Bertram G. Katzung (Paperback - Sep 21, 2000)
Excerpt:
... "States. Other synthetic drugs, including cyanoaziridine compounds (azimexon, ciamexon, and imexon) and methylinosine monophosphate, have been under investigation for the treatment" ...
More about this bookPrinciples and Practice of Gastrointestinal Oncology
by David P Kelsen, John M Daly, Scott E Kern, and Bernard Levin (Hardcover - Oct 1, 2007)
Excerpt:
... "cell proliferation Talabostat (PT-100) Fibroblast activation protein Flavopiridol Cyclin-dependent kinases Imexon Mitochondria EGFR, epidermal growth factor receptor; VEGF," ...
More about this bookCancer Cell Signaling: Methods and Protocols (Methods in Molecular Biology)
by David M. Terrian (Hardcover - Dec 9, 2002)
Excerpt:
... "stress and apoptosis in myeloma cells by the aziridine-containing agent imexon. Biochem. Pharmacol. 60, 749-758. Friesen, C., Fulda, S., and Debatin," ...
More about this bookBiologic Therapy of Leukemia (Contemporary Hematology)
by Matt Kalaycio (Hardcover - April 4, 2003)
Excerpt:
... "potentiation of arsenic trioxide cytotoxicity through novel combination therapy with Imexon for multiple myeloma [abstract 1580]. Blood 2001;98:375a. 23. Davison K," ...
More about this bookImmunotherapy in Cancer
by Martin Gore and Pamela Riches (Hardcover - Oct 22, 1996)
Excerpt:
... "diethyldithio- carbamates Azimexon, ciamexon, imexon AS101, tellurium chloride lsoprinosine Retinoids*, vitamin C PGE-2 synthesis inhibitors:" ...
More about this bookLymphoma: Webster's Timeline History, 2006
by Icon Group International (Paperback - Jun 6, 2009)
Excerpt:
... ": Authors of "Correlates of imexon sensitivity in human multiple myeloma cell lines," published in Leukemia" ...
More about this bookHuman Immunodeficiency Virus: Webster's Timeline History, 1937 - 1995
by Icon Group International (Paperback - May 1, 2009)
Excerpt:
... "Research Inst. of Infectious Diseases: Sponsored research "Antiviral Efficacy of Imexon in the Rauscher Murine Retrovirus AIDS Model." Sponsored by: Army" ...
More about this bookViral Therapy of Human Cancers (Basic and Clinical Oncology)
by Joseph G. Sinkovics and Joseph Horvath (Hardcover - Dec 28, 2004)
More about this book
medicine: imexon
imexon description
Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.
Tags
Keywords related to imexon
carfentanil retrovir aromasin ioglicic acid calcitriol lorfan salvia dibenzepin metrogel elcatonin herceptin cocaine layered double hydroxides ramatroban setiptiline telenzepine aristocort pegaspargase myotonachol sulfametoxydiazine arprinocid brotizolam allegra drug regadenoson azactam nortriptyline cytoxan catumaxomab budipine sulconazole alfentanil amitriptyline nardil letrozole aluminium hydroxide cedelizumab carbenoxolone paclitaxel lexapro dinoprost bontril mesulfen fluorometholone hetacillin lopirazepam crescormon norethandrolone taurolidine cortivazol allopurinol meglitinide
-
Related news
AmpliMed Corporation Announces Promising 1-year Survival Data from
3 /PRNewswire/ -- AmpliMed today reported one year survival results from a Phase I/II trial of its lead drug candidate, Amplimexon(R) (imexon for injection) ...
Read full articleLight bulb program.(DOMINICAN REPUBLIC)(Brief article) Article from
Imexon, a joint venture of Canadian and Colombian firms, says it has a contract worth US$15.75 million to supply 3 million fluorescent light bulbs, ...
Read full articleUS Oncology Affiliated Physicians Make a Strong Showing in ASCO
Kansas City Cancer Center-South: PhaseI/II study of imexon (AMP) plus dacarbazine (DTIC) in patients (Pts) with metastatic malignant melanoma Leukemia ...
Read full articleArticle: Las Vegas Gallery exhibits unique mix of painting, sculpture
by which AmpliMed's lead drug, Amplimexon(TM) (imexon inj may synergize with gemcitabine against human pancreatic cancer cells in vitro and in vivo. ...
Read full articleArizona Cancer Center Receives $6.5M to Test New Anticancer Drugs
Imexon was developed by Dorr; Evan M. Hersh, UA professor of The grant's second project, led by Dorr, will test Imexon in a clinical trial in ...
Read full articlePress Release: US Oncology Affiliated Physicians Make a Strong
Kansas City Cancer Center-South: PhaseI/II study of imexon (AMP) plus dacarbazine (DTIC) in patients (Pts) with metastatic malignant melanoma Leukemia ...
Read full articleAmpliMed Corporation Announces Start of Randomized Phase 2 Trial of
AmpliMed Corporation, a cancer therapeutics company, today announced that patient enrollment is underway in a Phase 2 trial of Amplimexon(R) (imexon for ...
Read full articleKOLD News 13 live, local and late breaking-Cancer Center Receives
PX-12 and Imexon are drugs that target cancer-causing proteins. The cancer center says Imexon "first showed activity against multiple myeloma and is ...
Read full articleAmpliMed Corporation to Present Clinical Data From Three Clinical
"A Phase I Study of Imexon Inj. Plus Gemcitabine as First-line Therapy for Advanced Pancreatic Cancer with Preclinical Mechanistic Study of Dose Limiting ...
Read full articlePress Release: AmpliMed Corporation Announces Promising 1-year
3 /PRNewswire/ -- AmpliMed today reported one year survival results from a Phase I/II trial of its lead drug candidate, Amplimexon(R) (imexon for injection) ...
Read full articleLarger etanercept dose has no added benefit.(Across Specialties)(
Article: Addition of imexon may improve chemotherapy for . The maximum tolerated dose of imexon was judged to be 1000 mg, as one patient in the highest ...
Read full article